The Europe Cervical Cancer Diagnostic Market would witness market growth of 4.0% CAGR during the forecast period (2023-2029).
The market has an opportunity owing to the rise in cervical cancer diagnostic tests in healthcare institutions. Additionally, the increased use of cutting-edge technology in introducing new products by numerous major companies is anticipated to benefit the development of the market. New diagnostic methods are being used to identify precancerous lesions, which are thought to represent the next generation of cervical cancer screening. These systems combine deep learning-based artificial intelligence (AI) with cutting-edge volumetric imaging technology.
Due to an increasing need for cervical cancer diagnostics among middle-aged patients, increased R&D activities, and improved test efficiency, the market is anticipated to grow at a high rate in emerging nations. Hospitals and other healthcare facilities are using cutting-edge equipment to detect cervical cancer. Additionally, the affordability of cervical cancer screening tests facilitates the development of the market.
Cervical cancer is becoming more common in this region; predictions indicate that in 2020, cervical cancer will account for 2.5% of all new cancer diagnoses in women in the EU-27 countries (excluding non-melanoma skin cancers) and 2.4% of all cancer-related deaths in women. Cervical cancer is amongst the most prevalent cancer and the most common cause of cancer mortality in women. Cervical cancer incidence and mortality rates were predicted to differ across the EU-27 by five and eight times, respectively, in 2020. This wide range is caused by the fact that varied HPV prevalence, vaccination, and cervical cancer screening programs exist in different EU countries. As a result, the region offers the market promising growth opportunities due to the rising incidences of cervical cancer and the efforts to enhance women's health.
The Germany market dominated the Europe Cervical Cancer Diagnostic Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $694.7 Million by 2029. The UK market is exhibiting a CAGR of 3.1% during (2023 - 2029). Additionally, The France market would display a CAGR of 4.8% during (2023 - 2029).
Based on Type, the market is segmented into Pap Smear Tests, Colposcopy Tests, HPV Test, Biopsy & ECC, and Others. Based on Age Group, the market is segmented into 20 to 40 years, and Above 40 years. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Cervical Cancer Diagnostic Market is Projected to reach USD 10.2 Billion by 2029, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Carl Zeiss AG, CooperSurgical, Inc. (The Cooper Companies, Inc.), DYSIS Medical, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Qiagen N.V., Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Pap Smear Tests
- Colposcopy Tests
- HPV Test
- Biopsy & ECC
- Others
By Age Group
- 20 to 40 years
- Above 40 years
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Becton, Dickinson and Company
- Carl Zeiss AG
- CooperSurgical, Inc. (The Cooper Companies, Inc.)
- DYSIS Medical, Inc.
- F.Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Qiagen N.V.
- Siemens Healthineers AG (Siemens AG)
- Thermo Fisher Scientific, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cervical Cancer Diagnostic Market, by Type
1.4.2 Europe Cervical Cancer Diagnostic Market, by Age Group
1.4.3 Europe Cervical Cancer Diagnostic Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.1.1 Partnerships, Collaborations and Agreements
3.1.2 Product Launches and Product Expansions
3.1.3 Acquisition and Mergers
3.1.4 Approvals and Trials
3.1.5 Geographical and Business Expansions
3.2 Top Winning Strategies
3.2.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. Europe Cervical Cancer Diagnostic Market by Type
4.1 Europe Pap Smear Tests Market by Country
4.2 Europe Colposcopy Tests Market by Country
4.3 Europe HPV Test Market by Country
4.4 Europe Biopsy & ECC Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Cervical Cancer Diagnostic Market by Age Group
5.1 Europe 20 to 40 years Market by Country
5.2 Europe Above 40 years Market by Country
Chapter 6. Europe Cervical Cancer Diagnostic Market by Country
6.1 Germany Cervical Cancer Diagnostic Market
6.1.1 Germany Cervical Cancer Diagnostic Market by Type
6.1.2 Germany Cervical Cancer Diagnostic Market by Age Group
6.2 UK Cervical Cancer Diagnostic Market
6.2.1 UK Cervical Cancer Diagnostic Market by Type
6.2.2 UK Cervical Cancer Diagnostic Market by Age Group
6.3 France Cervical Cancer Diagnostic Market
6.3.1 France Cervical Cancer Diagnostic Market by Type
6.3.2 France Cervical Cancer Diagnostic Market by Age Group
6.4 Russia Cervical Cancer Diagnostic Market
6.4.1 Russia Cervical Cancer Diagnostic Market by Type
6.4.2 Russia Cervical Cancer Diagnostic Market by Age Group
6.5 Spain Cervical Cancer Diagnostic Market
6.5.1 Spain Cervical Cancer Diagnostic Market by Type
6.5.2 Spain Cervical Cancer Diagnostic Market by Age Group
6.6 Italy Cervical Cancer Diagnostic Market
6.6.1 Italy Cervical Cancer Diagnostic Market by Type
6.6.2 Italy Cervical Cancer Diagnostic Market by Age Group
6.7 Rest of Europe Cervical Cancer Diagnostic Market
6.7.1 Rest of Europe Cervical Cancer Diagnostic Market by Type
6.7.2 Rest of Europe Cervical Cancer Diagnostic Market by Age Group
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Becton, Dickinson and Company
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 Carl Zeiss AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 CooperSurgical, Inc. (The Cooper Companies, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 DYSIS Medical, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Product Launches and Product Expansions:
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.6.5.3 Acquisition and Mergers:
7.7 Hologic, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Product Launches and Product Expansions:
7.7.5.3 Geographical Expansions:
7.8 Qiagen N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.8.5.2 Product Launches and Product Expansions:
7.8.5.3 Acquisition and Mergers:
7.9 Siemens Healthineers AG (Siemens AG)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 SWOT Analysis
7.10. Thermo Fisher Scientific, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis
TABLE 1 Europe Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 2 Europe Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cervical Cancer Diagnostic Market
TABLE 4 Product Launches And Product Expansions– Cervical Cancer Diagnostic Market
TABLE 5 Acquisition and Mergers– Cervical Cancer Diagnostic Market
TABLE 6 Approvals and trials– Cervical Cancer Diagnostic Market
TABLE 7 Geographical and Business Expansions– Cervical Cancer Diagnostic Market
TABLE 8 Europe Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 9 Europe Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 10 Europe Pap Smear Tests Market by Country, 2019 - 2022, USD Million
TABLE 11 Europe Pap Smear Tests Market by Country, 2023 - 2029, USD Million
TABLE 12 Europe Colposcopy Tests Market by Country, 2019 - 2022, USD Million
TABLE 13 Europe Colposcopy Tests Market by Country, 2023 - 2029, USD Million
TABLE 14 Europe HPV Test Market by Country, 2019 - 2022, USD Million
TABLE 15 Europe HPV Test Market by Country, 2023 - 2029, USD Million
TABLE 16 Europe Biopsy & ECC Market by Country, 2019 - 2022, USD Million
TABLE 17 Europe Biopsy & ECC Market by Country, 2023 - 2029, USD Million
TABLE 18 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 19 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 20 Europe Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 21 Europe Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 22 Europe 20 to 40 years Market by Country, 2019 - 2022, USD Million
TABLE 23 Europe 20 to 40 years Market by Country, 2023 - 2029, USD Million
TABLE 24 Europe Above 40 years Market by Country, 2019 - 2022, USD Million
TABLE 25 Europe Above 40 years Market by Country, 2023 - 2029, USD Million
TABLE 26 Europe Cervical Cancer Diagnostic Market by Country, 2019 - 2022, USD Million
TABLE 27 Europe Cervical Cancer Diagnostic Market by Country, 2023 - 2029, USD Million
TABLE 28 Germany Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 29 Germany Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 30 Germany Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 31 Germany Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 32 Germany Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 33 Germany Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 34 UK Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 35 UK Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 36 UK Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 37 UK Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 38 UK Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 39 UK Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 40 France Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 41 France Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 42 France Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 43 France Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 44 France Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 45 France Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 46 Russia Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 47 Russia Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 48 Russia Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 49 Russia Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 50 Russia Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 51 Russia Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 52 Spain Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 53 Spain Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 54 Spain Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 55 Spain Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 56 Spain Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 57 Spain Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 58 Italy Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 59 Italy Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 60 Italy Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 61 Italy Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 62 Italy Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 63 Italy Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 64 Rest of Europe Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
TABLE 65 Rest of Europe Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
TABLE 66 Rest of Europe Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
TABLE 67 Rest of Europe Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
TABLE 68 Rest of Europe Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
TABLE 69 Rest of Europe Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
TABLE 70 Key Information – Abbott Laboratories
TABLE 71 Key information – Becton, Dickinson and Company
TABLE 72 key Information – Carl Zeiss AG
TABLE 73 Key Information – CooperSurgical, Inc.
TABLE 74 Key information – DYSIS Medical, Inc.
TABLE 75 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 76 Key Information – Hologic, Inc.
TABLE 77 Key Information – Qiagen N.V.
TABLE 78 Key Information – Siemens Healthineers AG
TABLE 79 Key Information – Thermo Fisher Scientific, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Europe Cervical Cancer Diagnostic Market share by Type, 2022
FIG 5 Europe Cervical Cancer Diagnostic Market share by Type, 2029
FIG 6 Europe Cervical Cancer Diagnostic Market by Type, 2019 - 2029, USD Million
FIG 7 Europe Cervical Cancer Diagnostic Market share by Age Group, 2022
FIG 8 Europe Cervical Cancer Diagnostic Market share by Age Group, 2029
FIG 9 Europe Cervical Cancer Diagnostic Market by Age Group, 2019 - 2029, USD Million
FIG 10 Europe Cervical Cancer Diagnostic Market share by Country, 2022
FIG 11 Europe Cervical Cancer Diagnostic Market share by Country, 2029
FIG 12 Europe Cervical Cancer Diagnostic Market by Country, 2019 - 2029, USD Million
FIG 13 Swot analysis: Abbott laboratories
FIG 14 Recent strategies and developments: Becton, Dickinson and Company
FIG 15 Swot analysis: Becton, Dickinson and company
FIG 16 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 17 Recent strategies and developments: Hologic, Inc.
FIG 18 Recent strategies and developments: Qiagen N.V.
FIG 19 Swot analysis: Siemens AG
FIG 20 Swot analysis: thermo fisher scientific, inc.